NeuroMetrix Inc at Emerging Growth Conference (Virtual) Transcript

Oct 04, 2023 / 07:55PM GMT
Ana Berry - - Moderator

Dr. Shai Gozani, Chairman and CEO of NeuroMetrix, Inc. For business update, NeuroMetrix trades on the Nasdaq under the symbol NURO and is a neuromodulation company developing novel treatments for chronic pain syndromes. Welcome back, Doctor. How are you today?

Shai Gozani - NeuroMetrix, Inc. - President, CEO & Chairman

I'm great. Thank you very much, Ana. We appreciate the opportunity to update today. So just very briefly, this is our forward-looking statements. A disclaimer, please take a look at our recently filed Qs as well as our 10-K for assessment of and list of risk factors.

So just as a reminder, NeuroMetrix is a Boston-based medical device company. Our mission is to improve the lives of patients with chronic pain through neuromodulation devices. And just diving into that a little bit, we focus on intractable chronic pain, which are those forms of chronic pain that really are resistant to typical treatments.

We believe that we are well positioned based on our recent clinical and regulatory

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot